SOONER STATE CCOP
更快的州 CCOP
基本信息
- 批准号:6144454
- 负责人:
- 金额:$ 54.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-09-22 至 2002-05-31
- 项目状态:已结题
- 来源:
- 关键词:United States cancer prevention clinical research clinical trials community health services cooperative study experimental designs health care quality health care service availability health services research tag human subject human therapy evaluation medical outreach /case finding medically underserved population neoplasm /cancer education neoplasm /cancer therapy primary care physician rural area
项目摘要
The specific aim of the Sooner State CCOP is to provide the communities throughout the state with access to NCI-approved clinical trials which encompass cancer treatment and cancer control studies. Long-term objectives include: 1) Increasing the availability of NCI-approved clinical trials to the substantial underserved rural and minority populations in the state; 2) Expanding the involvement of community physicians in cancer prevention and cancer control projects; 4) Increasing patient accrual to NCI clinical trials; 5) Measuring the impact that the availability of NCI clinical trials has on clinical outcomes in the state. First, the Sooner State CCOP is a single component, Cancer Care Associates, Inc (CCA), a private practice oncology group with a statewide network of 32 medical, surgical, and radiation oncologists at 22 separate locations throughout the state. The CCOP will create new alliances with location practitioners statewide resulting in continued growth in patient referrals and increased availability of NCI clinical trials through association with multiple cooperative groups: NCCTG, ECOG, NSABP, GOG, and RTOG. Second, research nurses will implement screening of medical records at multiple sites for potential participants in clinical trials. A research nurse at each of the two primary research hubs will be responsible solely for activation of prevention and cancer control studies their respective regions. Previous experience in activating major prevention trials (BCPT and PCPT) led to the endorsement of numerous community resources which will be expanded. Third, multiple CCA satellite offices in rural communities provide local cancer care services not previously available, as well as access to NCI clinical trials and prevention/control studies. The collective resources and expertise of CCA physicians and staff provides numerous benefits in quality cancer and treatment options not usually available in rural communities. Fourth, the CCOP will implement a computer network connecting all sites and an electronic medical record which will improve disease management and provide data on cost effectiveness and patient outcomes previous impossible to obtain. Analysis of this data will hopefully demonstrate the benefits of clinical trials participation to major insurance and managed care providers.
Sooner State CCOP的具体目标是为全州社区提供获得NCI批准的临床试验的机会,其中包括癌症治疗和癌症控制研究。长期目标包括:1)增加国家癌症研究所批准的临床试验的可获得性,以大量服务不足的农村和少数民族人口在国家; 2)扩大社区医生参与癌症预防和癌症控制项目; 4)增加NCI临床试验的患者增加; 5)衡量NCI临床试验的可用性对国家临床结果的影响。首先,Sooner State CCOP是一个单一的组成部分,癌症护理协会(CCA),一个私人执业肿瘤学团体,在全州22个不同的地点拥有32名医疗,外科和放射肿瘤学家的全州网络。CCOP将与全州的位置从业者建立新的联盟,通过与多个合作小组(NCCTG,ECOG,NSABP,GOG和RTOG)的联系,使患者转诊持续增长,并增加NCI临床试验的可用性。其次,研究护士将在多个研究中心对临床试验的潜在参与者进行病历筛选。两个主要研究中心的研究护士将单独负责启动各自区域的预防和癌症控制研究。以往在启动重大预防试验(BCPT和PCPT)方面的经验导致了众多社区资源的认可,这些资源将得到扩大。第三,在农村社区的多个CCA卫星办事处提供以前没有的当地癌症护理服务,以及获得NCI临床试验和预防/控制研究。CCA医生和工作人员的集体资源和专业知识为农村社区通常无法获得的高质量癌症和治疗选择提供了许多好处。第四,CCOP将实施一个连接所有站点的计算机网络和电子病历,这将改善疾病管理,并提供以前无法获得的成本效益和患者结果数据。对这些数据的分析将有望证明临床试验参与对主要保险和管理式医疗提供者的益处。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ALAN M KELLER其他文献
ALAN M KELLER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ALAN M KELLER', 18)}}的其他基金
SAINT FRANCIS HOSPITAL/NATALIE WARREN BRYANT CCOP
圣弗朗西斯医院/NATALIE WARREN BRYANT CCOP
- 批准号:
3558646 - 财政年份:1987
- 资助金额:
$ 54.83万 - 项目类别:
SAINT FRANCIS HOSPITAL/NATALIE WARREN BRYANT CCOP
圣弗朗西斯医院/NATALIE WARREN BRYANT CCOP
- 批准号:
3558645 - 财政年份:1987
- 资助金额:
$ 54.83万 - 项目类别:
相似海外基金
CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
癌症预防剂开发计划:早期临床研究
- 批准号:
10425188 - 财政年份:2021
- 资助金额:
$ 54.83万 - 项目类别:
CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
癌症预防剂开发计划:早期临床研究
- 批准号:
10683047 - 财政年份:2021
- 资助金额:
$ 54.83万 - 项目类别:
CONTRACT TITLE - CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
合同名称 - 癌症预防剂开发计划:早期临床研究
- 批准号:
10223848 - 财政年份:2020
- 资助金额:
$ 54.83万 - 项目类别:
CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
癌症预防剂开发计划:早期临床研究
- 批准号:
10452466 - 财政年份:2019
- 资助金额:
$ 54.83万 - 项目类别:
CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
癌症预防剂开发计划:早期临床研究
- 批准号:
10894578 - 财政年份:2019
- 资助金额:
$ 54.83万 - 项目类别:
OTHER FUNCTIONS - CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
其他功能 - 癌症预防剂开发计划:早期临床研究
- 批准号:
10425187 - 财政年份:2019
- 资助金额:
$ 54.83万 - 项目类别:
CONTRACT TITLE - CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
合同名称 - 癌症预防剂开发计划:早期临床研究
- 批准号:
10045660 - 财政年份:2019
- 资助金额:
$ 54.83万 - 项目类别:
OTHER FUNCTIONS - CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
其他功能 - 癌症预防剂开发计划:早期临床研究
- 批准号:
10691840 - 财政年份:2019
- 资助金额:
$ 54.83万 - 项目类别:
CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
癌症预防剂开发计划:早期临床研究
- 批准号:
10045662 - 财政年份:2019
- 资助金额:
$ 54.83万 - 项目类别:
OTHER FUNCTIONS - CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
其他功能 - 癌症预防剂开发计划:早期临床研究
- 批准号:
10045663 - 财政年份:2019
- 资助金额:
$ 54.83万 - 项目类别:














{{item.name}}会员




